Primary sclerosing cholangitis: best practices for diagnosis

References

• Molodecky NA, Kareemi H, Parab R, et al. Incidence of primary sclerosing cholangitis: a systematic review and meta-analysis. Hepatology. 2011;53:1590–1599.
   Google Scholar
• Boonstra K, Beuers U, Ponsioen CY. Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: a systematic review. J Hepatol. 2012;56:1181–1188.
   Google Scholar
• Lindkvist B. Benito de Valle M, Gullberg B, Björnsson E. Incidence and prevalence of primary sclerosing cholangitis in a defined adult population in Sweden. Hepatology. 2010;52:571–577.
   Google Scholar
• Broomé U, Olsson R, Lööf L, et al. Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis. Gut. 1996;38:610–615.
   Google Scholar
• Benito de Valle M, Björnsson E, Lindkvist B. Mortality and cancer risk related to primary sclerosing cholangitis in a Swedish population-based cohort. Liver Int. 2012;32:441–448.
   Google Scholar
• Boonstra K, Weersma RK, van Erpecum KJ, et al. Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis. Hepatology. 2013;58:2045–2055.
   Google Scholar
• Boberg KM, Bergquist A, Mitchell S, et al. Cholangiocarcinoma in primary sclerosing cholangitis: risk factors and clinical presentation. Scand J Gastroenterol. 2002;37:1205–1211.
   Google Scholar
• Chapman R, Fevery J, Kalloo A, et al. Diagnosis and management of primary sclerosing cholangitis. Hepatology. 2010;51:660–678.
   Google Scholar
• Lindor KD, Kowdley KV, Harrison ME. ACG clinical guideline: primary sclerosing cholangitis. Am J Gastroenterol. 2015;110:646–659.
   Google Scholar
• Fosby B, Melum E, Bjøro K, et al. Liver transplantation in the Nordic countries - an intention to treat and post-transplant analysis from the nordic liver transplant registry 1982-2013. Scand J Gastroenterol. 2015;50:797–808.
   Google Scholar
• Weismuller TJ, Trivedi PJ, Bergquist A, et al. Patient age, sex, and inflammatory bowel disease phenotype associate with course of primary sclerosing cholangitis. Gastroenterology. 2017 Mar 6. pii: S0016-5085(17)30236-6. Epub ahead of print. DOI:10.1053/j.gastro.2017.02.038
   Google Scholar
• Björnsson E, Boberg KM, Cullen S, et al. Patients with small duct primary sclerosing cholangitis have a favourable long term prognosis. Gut. 2002;51:731–735.
   Google Scholar
• Broomé U, Glaumann H, Lindstöm E, et al. Natural history and outcome in 32 Swedish patients with small duct primary sclerosing cholangitis (PSC). J Hepatol. 2002;36:586–589.
   Google Scholar
• Angulo P, Maor-Kendler Y, Lindor KD. Small-duct primary sclerosing cholangitis: a long-term follow-up study. Hepatology. 2002;35:1494–1500.
   Google Scholar
• Björnsson E, Olsson R, Bergquist A, et al. The natural history of small-duct primary sclerosing cholangitis. Gastroenterology. 2008;134:975–980.
   Google Scholar
• Wiesner RH, Grambsch PM, Dickson ER, et al. Primary sclerosing cholangitis: natural history, prognostic factors and survival analysis. Hepatology. 1989;10:430–436.
   Google Scholar
• Okolicsanyi L, Fabris L, Viaggi S, et al. Primary sclerosing cholangitis: clinical presentation, natural history and prognostic variables: an Italian multicentre study. The Italian PSC study group. Eur J Gastroenterol Hepatol. 1996;8:685–691.
   Google Scholar
• Kaplan GG, Laupland KB, Butzner D, et al. The burden of large and small duct primary sclerosing cholangitis in adults and children: a population-based analysis. Am J Gastroenterol. 2007;102:1042–1049.
   Google Scholar
• Björnsson E, Simren M, Olsson R, et al. Fatigue in patients with primary sclerosing cholangitis. Scand J Gastroenterol. 2004;39:864–869.
   Google Scholar
• Olsson R, Broomé U, Danielsson A, et al. Spontaneous course of symptoms in primary sclerosing cholangitis: relationships with biochemical and histological features. Hepatogastroenterology. 1999;46(25):136–141.
   Google Scholar
• Balasubramaniam K, Wiesner RH, LaRusso NF. Primary sclerosing cholangitis with normal serum alkaline phosphatase activity. Gastroenterology. 1988;95:1395–1398.
   Google Scholar
• Kaya M, Angulo P, Lindor KD. Overlap of autoimmune hepatitis and primary sclerosing cholangitis: an evaluation of a modified scoring system. J Hepatol. 2000;33:537–542.
   Google Scholar
• Björnsson E, Lindqvist-Ottosson J, Asztely M, et al. Dominant strictures in patients with primary sclerosing cholangitis. Am J Gastroenterol. 2004;99:502–508.
   Google Scholar
• Bansi D, Chapman R, Fleming K. Antineutrophil cytoplasmic antibodies in chronic liver diseases: prevalence, titre, specificity and IgG subclass. J Hepatol. 1996;24:581–586.
   Google Scholar
• Mulder AH, Horst G, Haagsma EB, et al. Prevalence and characterization of neutrophil cytoplasmic antibodies in autoimmune liver diseases. Hepatology. 1993;17:411–417.
   Google Scholar
• Navaneethan U, Jegadeesan R, Nayak S, et al. ERCP-related adverse events in patients with primary sclerosing cholangitis. Gastrointest Endosc. 2015;81:410–419.
   Google Scholar
• Von Seth E, Arnelo U, Enochsson L, et al. Primary sclerosing cholangitis increases the risk for pancreatitis after endoscopic retrograde cholangiopancreatography. Liver Int. 2015;35:254–262.
   Google Scholar
• Olsson R, Björnsson E, Bäckman L, et al. Bile duct bacterial isolates in primary sclerosing cholangitis: a study of explanted livers. J Hepatol. 1998;28:426–432.
   Google Scholar
• Björnsson ES, Kilander AF, Olsson RG. Bile duct bacterial isolates in primary sclerosing cholangitis and certain other forms of cholestasis–a study of bile cultures from ERCP. Hepatogastroenterology. 2000;47:1504–1508.
   Google Scholar
• Njei B, McCarty TR, Varadarajulu S, et al. Systematic review with meta-analysis: endoscopic retrograde cholangiopancreatography-based modalities for the diagnosis of cholangiocarcinoma in primary sclerosing cholangitis. Aliment Pharmacol Ther. 2016;44:1139–1151.
   Google Scholar
• Quinn KP, Tabibian JH, Lindor KD. Clinical implications of serial versus isolated biliary fluorescence in situ hybridization (FISH) polysomy in primary sclerosing cholangitis. Scand J Gastroenterol. 2017;52:377–381.
   Google Scholar
• Talwalkar JA, Angulo P, Johnson CD, et al. Cost-minimization analysis of MRC versus ERCP for the diagnosis of primary sclerosing cholangitis. Hepatology. 2004;40:39–45.
   Google Scholar
• Dave M, Elmunzer BJ, Dwamena BA, et al. Primary sclerosing cholangitis: meta-analysis of diagnostic performance of MR cholangiopancreatography. Radiology. 2010;256:387–396.
   Google Scholar
• MacCarty RL, LaRusso NF, Wiesner RH, et al. Primary sclerosing cholangitis: findings on cholangiography and pancreatography. Radiology. 1983;149:39–44.
   Google Scholar
• Ludwig J. Surgical pathology of the syndrome of primary sclerosing cholangitis. Am J Surg Pathol. 1989;13(suppl 1):43–49.
   Google Scholar
• Burak KW, Angulo P, Lindor KD. Is there a role for liver biopsy in primary sclerosing cholangitis? Am J Gastroenterol. 2003;98:1155–1158.
   Google Scholar
• Juliusson G, Imam M, Björnsson ES, et al. Long-term outcomes in antimitochondrial antibody negative primary biliary cirrhosis. Scand J Gastroenterol. 2016;51:745–752.
   Google Scholar
• Maggio MC, Liotta A, Cardella F, et al. Stevens-Johnson syndrome and cholestatic hepatitis induced by acute Epstein-Barr virus infection. Eur J Gastroenterol Hepatol. 2011;23:289.
   Google Scholar
• Leonardsson H, Löve A, Björnsson ES. Hepatitis due to Epstein-Barr virus and cytomegalovirus: clinical features and outcome. Scand J Gastroenterol. 2017;52:893–897.
   Google Scholar
• Torkadi PP, Apte IC, Bhute AK. Biochemical evaluation of patients of alcoholic liver disease and non-alcoholic liver disease. Indian J Clin Biochem. 2014;29:79–83.
   Google Scholar
• Bjornsson E, Jonasson JG. Cholestasis due to drugs. Clin Liv Dis. 2013;17:91–209.
   Google Scholar
• Kremer AE, Namer B, Bolier R, et al. Pathogenesis and management of pruritus in PBC and PSC. Dig Dis. 2015;33(Suppl 2):164–175.
   Google Scholar
• Björnsson ES, Hoofnagle JH. Categorization of drugs implicated in causing liver injury: critical assessment based upon published case reports. Hepatology. 2016;63:590–603.
   Google Scholar
• Floreani A, Rizzotto ER, Ferrara F, et al. Clinical course and outcome of autoimmune hepatitis/primary sclerosing cholangitis overlap syndrome. Am J Gastroenterol. 2005;100:1516–1522.
   Google Scholar
• Olsson R, Lindgren S, Glaumann H, et al. High prevalence of small-duct primary sclerosing cholangitis among patients with overlapping autoimmune hepatitis and primary sclerosing cholangitis. Eur J Int Med. 2009;20:190–196.
   Google Scholar
• Hennes EM, Zeniya M, Czaja AJ, et al. Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology. 2008;48:169–176.
   Google Scholar
• Gossard A, Angulo P, Lindor KD. Secondary sclerosing cholangitis: a focus on secondary causes. Hepatology. 2006;4:1063–1074.
   Google Scholar
• Abdalian R, Heathcote EJ. Sclerosing cholangitis: a focus on secondary causes. Hepatology (Baltimore, Md). 2006;44:1063–1074.
   Google Scholar
• Imam MH, Talwalkar JA, Lindor KD. Secondary sclerosing cholangitis: pathogenesis, diagnosis, and management. Clin Liver Dis. 2013 May;17(2):269–277.
   Google Scholar
• Sperling RM, Koch J, Sandhu JS, et al. Recurrent pyogenic cholangitis in Asian immigrants to the United States: natural history and role of therapeutic ERCP. Dig Dis Sci. 1997;42:865–871.
   Google Scholar
• Zammit SC, Gerada J, Attard J, et al. Secondary sclerosing cholangitis uncovered during endoscopic retrograde cholangiopancreatography in a patient with chronic choledocholithiasis. Case Rep Intern Med. 2014;1:1–2.
   Google Scholar
• Siqueira E, Schoen RE, Silverman W, et al. Detecting cholangiocarcinoma in patients with primary sclerosing cholangitis. Gastrointest Endosc. 2002;56:40–47.
   Google Scholar
• Björnsson E, Chari S, Smyrk T, et al. Immunoglobuling G4 associated cholangitis. Description of an emerging clinical entity based on reviw of the literature. Hepatology. 2007;45:1547–1554.
   Google Scholar
• Mourad MM, Liossis C, Gunson BK, et al. Etiology and management of hepatic artery thrombosis after adult liver transplantation. Liver Transpl. 2014;20:713–723.
   Google Scholar
• Watanabe H, Ohira H, Kuroda M, et al. Primary sclerosing cholangitis with marked eosinophilic infiltration in the liver. J Gastroenterol. 1995;30:524–528.
   Google Scholar
• Forbes A, Blanshard C, Gazzard B. Natural history of AIDS related sclerosing cholangitis: a study of 20 cases. Gut. 1993;34:116–121.
   Google Scholar
• Benninger J, Grobholz R, Oeztuerk Y, et al. Sclerosing cholangitis following severe trauma: description of a remarkable disease entity with emphasis on possible pathophysiologic mechanisms. World J Gastroenterol. 2005;11:4199–4205.
   Google Scholar
• Gelbmann CM, Rummele P, Wimmer M, et al. Ischemic-like cholangiopathy with secondary sclerosing cholangitis in critically ill patients. Am J Gastroenterol. 2007;102:1221–1229.
   Google Scholar
• Wei L, Weije C, Xiadong H, et al. Poor response to initial steroid therapy for IgG4-related sclerosing cholangits with multiple organs affected. J Hepatobiliary Pancreat Sci. 2012;19:536–542.
   Google Scholar
• Moon SH, Kim MH, Lee JK, et al. Development of a scoring system for differentiating IgG4-related sclerosing cholangitis from primary sclerosing cholangitis. J Gastroenterol. 2017;52:483–493.
   Google Scholar
• Folseraas T, Boberg KM. Cancer risk and surveillance in primary sclerosing cholangitis. Clin Liver Dis. 2016;20:79–98.
   Google Scholar
• Björnsson E, Kilander A, Olsson R. CA 19-9 and CEA are unreliable markers for cholangiocarcinoma in patients with primary sclerosing cholangitis. Liver. 1999;19:501–508.
   Google Scholar
• Bangarulingam SY, Gossard AA, Petersen BT, et al. Complications of endoscopic retrograde cholangiopancreatography in primary sclerosing cholangitis. Am J Gastroenterol. 2009;104:855–860.
   Google Scholar
• Heif M, Yen RD, Shah RJ. ERCP with probe-based confocal laser endomicroscopy for the evaluation of dominant biliary stenoses in primary sclerosing cholangitis patients. Dig Dis Sci. 2013;58:2068–2074.
   Google Scholar
• Karia K, Jamal-Kabani A, Gaidhane M, et al. probe-based confocal endomicroscopy in primary sclerosing cholangitis: not all inflammatory strictures are the same. Dig Dis Sci. 2016;61:283–286.
   Google Scholar
• Khuroo MS, Yattoo GN, Zargar SA, et al. Biliary abnormalities associated with extrahepatic portal venous obstruction. Hepatology. 1993;17:807–813.
   Google Scholar
• Ludwig J, Kim CH, Wiesner RH, et al. Floxuridine-induced sclerosing cholangitis: an ischemic cholangiopathy? Hepatology (Baltimore, Md.). 1989 Feb;9(2):215–218.
   Google Scholar
• Schwab GP, Wetscher GJ, Vogl W, et al. Methimazole-induced cholestatic liver injury, mimicking sclerosing cholangitis. Langenbecks Arch Chir. 1996;381(4):225–227.
   Google Scholar
• Seto WK, Ng M, Chan P, et al. Ketamine-induced cholangiopathy: a case report. Am J Gastroenterol. 2011 May;106(5):1004–1005.
   Google Scholar
• Horsley-Silva JL, Dow EN, Menias CO, et al. Docetaxel induced sclerosing cholangitis. Dig Dis Sci. 2015;60:3814–3816.
   Google Scholar
• Gudnason HO, Björnsson HK, Gardarsdottir M, et al. Secondary sclerosing cholangitis in patients with drug-induced liver injury. Dig Liv Dis. 2015;47:502–507.
   Google Scholar
• Björnsson E, Chari S, Talwalkar J, et al. Primary sclerosing cholangitis associated with elevated immunoglobulinG4: clinical characteristics and response to immunosuppressive therapy. Am J Ther. 2010;18:198–205.
   Google Scholar